17 results
PRE 14A
FULC
Fulcrum Therapeutics Inc
18 Apr 23
Preliminary proxy
4:05pm
over financial reporting, disclosure controls and procedures and code of business conduct and ethics;
overseeing our risk assessment and risk … of stockholders.
Code of Business Conduct and Ethics
We have adopted a written code of business conduct and ethics that applies to our directors
8-K
EX-1.1
64zcdr47z0s lhnjk0ig
16 Aug 22
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
5:59pm
DEF 14A
mipcj6fi7nurhknj332
29 Apr 20
Definitive proxy
9:21am
10-K
29lt9qnp q0
5 Mar 20
Annual report
4:01pm
424B4
sml90mmfkpqu1xs
18 Jul 19
Prospectus supplement with pricing info
5:19pm
S-1/A
2e9oitfmagcv
8 Jul 19
IPO registration (amended)
6:04am
S-1
tmr ubddrl5z
21 Jun 19
IPO registration
4:26pm
DRS/A
pxe89o
6 Jun 19
Draft registration statement (amended)
12:00am
DRS
c91b0p67hw226dc2iu
1 May 19
Draft registration statement
12:00am
- Prev
- 1
- Next